Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies
- 1 June 2015
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 16 (6) , e293-e302
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaActa Neuropathologica, 2013
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomasActa Neuropathologica, 2013
- Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysisThe Lancet Oncology, 2012
- Novel mutations target distinct subgroups of medulloblastomaNature, 2012
- Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 MutationsCell, 2012
- MAPK pathway activation in pilocytic astrocytomaCellular and Molecular Life Sciences, 2011
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- An Integrated In Vitro and In Vivo High-Throughput Screen Identifies Treatment Leads for EpendymomaCancer Cell, 2011
- Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain TumorsCancer Cell, 2009
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007